A Favorable 3-Year Outcome of Kidney Transplantation in Atypical Hemolytic Uremic Syndrome Associated With a Factor H Mutation: Case Report

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1352-1354

  Albertazzi, V ^a   Bonucchi, D ^a   De Amicis, S ^a   Americo, C ^a   Ghiandai, G ^a   Cappelli, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; CORTICOSTEROID DERIVATIVE; CYTOSINE; FRESH FROZEN PLASMA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMINE;

ADULT; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; ENTEROCOCCAL INFECTION; FEMALE; GENETIC ASSOCIATION; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HETEROZYGOSITY; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEPHRECTOMY; PERITONEAL DIALYSIS; PLASMA TRANSFUSION; PLASMAPHERESIS; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT RESPONSE;

ADULT; CADAVER; COMPLEMENT FACTOR H; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; TISSUE DONORS;

EID: 77952558567     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.048     Document Type: Article

References (7)

1. Loirat C., Noris M., and Fremeaux-Bacchi V. Complement and atypical hemolytic uremic syndrome in children. Pediatr Nephrol 23 (2008) 1957
2. Noris M., and Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 361 (2009) 1676
3. Bresin E., Daina E., Noris M., et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin J Am Soc Nephrol 1 (2006) 88
4. Remuzzi G., Ruggenenti P., Colledan M., et al. Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. Am J Transplant 5 (2005) 1146
5. Saland J.M., Emre S.H., Shneider B.L., et al. A favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant 6 (2006) 1948
6. Caprioli J., Noris M., Brioschi S., et al. Genetics of HUS: the impact of MCP, CFH and IF on clinical presentation, response to treatment, and outcome. Blood 108 (2006) 1267
7. Olie K.H., Goodship T.H., Verlaak R., et al. Posttransplantation cytomegalovirus-induced recurrence of atypical hemolytic uremic syndrome associated with a factor H mutation: successful treatment with intensive plasma exchange and ganciclovir. Am J Kidney Dis 45 (2005) e12